Characterization of the population that consults by epistaxis to the Otolaryngology Service of the Hospital Universitario Mayor Méderi (HUM)
Main Article Content
Abstract
Introduction: Epistaxis is one of the main reasons for emergency consultation in the Otolaryngology department. Most episodes originate in the anterior nasal septum and their management tends to be conservative. Objective: To characterize the population that consults for epistaxis at the Otolaryngology service of the Hospital Universitario Mayor Méderi (HUM) between March 2017 and February 2018. Methodology: Observational, descriptive, cross-sectional study, with retrospective data collection of patients admitted to the HUM emergency room for epistaxis, registered in the Otolaryngology service database. Demographic data, location of bleeding, treatment, comorbidities, drugs and blood pressure were analyzed.
Article Details
Section

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Este artículo es publicado por la Revista Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello.
Este es un artículo de acceso abierto, distribuido bajo los términos de la LicenciaCreativeCommons Atribución-CompartirIgual 4.0 Internacional.( http://creativecommons.org/licenses/by-sa/4.0/), que permite el uso no comercial, distribución y reproducción en cualquier medio, siempre que la obra original sea debidamente citada.
eISSN: 2539-0856
ISSN: 0120-8411
How to Cite
References
1. Bequignon E, Vérillaud B, Robard L, Michel J, Prulière Escabasse V, Crampette L, et al. Guidelines of the French Society of Otorhinolaryngology (SFORL). First-line treatment of epistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(3):185-9. doi:10.1016/j.anorl.2016.09.008
2. Al-bar MH. Epistaxis and catastrophic nasal bleeding. OperTech Otolaryngol - Head Neck Surg. 2014;25(2):194-200. doi:10.1016/j.otot.2014.02.010
3. Davies K, Batra K, Mehanna R, Keogh I. Pediatric epistaxis:epidemiology, management & impact on quality of life. Int JPediatr Otorhinolaryngol. 2014;78(8):1294-97. doi:10.1016/j.ijporl.2014.05.013
4. Kasperek ZA, Pollock GF. Epistaxis: an overview. Emerg Med Clin North Am. 2013;31(2):443-454. doi:10.1016/j.emc.2013.01.008
5. Kindler RM, Holzmann D, Landis BN, Ditzen B, Soyka MB. The high rate of long-term recurrences and sequelae after epistaxis treatment. Auris Nasus Larynx. 2016;43(4):412-7.doi:10.1016/j.anl.2015.09.011
6. Verillaud B, Robard L, Michel J, Pruliere Escabasse V, Béquignon E, et al. Guidelines of the French Society of Otorhinolaryngology (SFORL). Second-line treatment ofepistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis.2017;134(3):191-193. doi:10.1016/j.anorl.2016.09.009
7. Lin G, Bleier B. Surgical Management of Severe Epistaxis.Otolaryngol Clin North Am. 2016;49(3):627-37. doi:10.1016/j.otc.2016.01.003
8. Monjas-Cánovas I, Hernández-García I, Mauri-Barberá J, Sanz- Romero B, Gras-Albert JR. Epidemiología de las epistaxisingresadas en un hospital de tercer nivel. Acta OtorrinolaringolEsp. 2010;61(1):41–7.
9. Pallin DJ, Chng YM, McKay MP, Emond JA, Pelletier AJ,Camargo CA Jr. Epidemiology of epistaxis in US emergency departments, 1992 to 2001. Ann Emerg Med. 2005;46(1):77-81.doi:10.1016/j.annemergmed.2004.12.014
10. Viehweg TL, Roberson JB, Hudson JW. Epistaxis: diagnosis and treatment. J Oral Maxillofac Surg. 2006;64(3):511-518.doi:10.1016/j.joms.2005.11.031
11. Ando Y, Iimura J, Arai S, et al. Risk factors for recurrent epistaxis: importance of initial treatment. Auris Nasus Larynx.2014;41(1):41-45. doi:10.1016/j.anl.2013.05.004
12. Corr MJ, Tikka T, Douglas CM, Marshall J. One-year all-cause mortality for 338 patients admitted with epistaxis in a largetertiary ENT centre. J Laryngol Otol. 2019;133(6):487-493.doi:10.1017/S0022215119000860
13. Newton E, Lasso A, Petrcich W, Kilty SJ. An outcomes analysis of anterior epistaxis management in the emergency department. J Otolaryngol Head Neck Surg. 2016;45:24. doi:10.1186/s40463-016-0138-2
14. Kubba H, MacAndie C, Botma M, et al. A prospective, singleblind, randomized controlled trial of antiseptic cream for recurrent epistaxis in childhood. Clin Otolaryngol Allied Sci.2001;26(6):465-468. doi:10.1046/j.1365-2273.2001.00502.x
15. Abrich V, Brozek A, Boyle TR, Chyou PH, Yale SH. Risk factors for recurrent spontaneous epistaxis. Mayo Clin Proc. Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello. 2020; 48(3): 44(2): 92-99 33 2014;89(12):1636-1643. doi:10.1016/j.mayocp.2014.09.009
16. Terakura M, Fujisaki R, Suda T, Sagawa T, Sakamoto T.Relationship between blood pressure and persistent epistaxis at the emergency department: a retrospective study. J Am Soc Hypertens. 2012;6(4):291-295. doi:10.1016/j.jash.2012.05.001
17. Lubianca Neto JF, Fuchs FD, Facco SR, et al. Is epistaxis evidence of end-organ damage in patients with hypertension?. Laryngoscope. 1999;109(7 Pt 1):1111-15.doi:10.1097/00005537-199907000-00019
18. Min HJ, Kang H, Choi GJ, Kim KS. Association between Hypertension and Epistaxis: Systematic Review and Metaanalysis. Otolaryngol Head Neck Surg. 2017;157(6):921-927.doi:10.1177/0194599817721445